Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 14 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 8883781

    Thienopyrimidines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted
  2. US 8877759

    Aminopyrazines as ATR kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted
  3. US 8871904

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  4. US 8871774

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  5. US 8865751

    Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  6. US 8865771

    Amides useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  7. US 8853254

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  8. US 8853152

    Pharmaceutical compositions

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  9. US 8853217

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  10. US 8853244

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  11. US 8853415

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  12. US 8846917

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  13. US 8846686

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  14. US 8846918

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  15. US 8846718

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxo1-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  16. US 8846896

    Methods of preparing substituted nucleotide analogs

    Vertex Pharmaceuticals Incorporated · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  17. US 8846753

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  18. US 8841449

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  19. US 8841450

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  20. US 8841483

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  21. US 8841282

    Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  22. US 8841337

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  23. US 8841308

    Pyrazin-2-amines useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  24. US 8835639

    Process for making modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted